Male Infertility Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2035
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
GlobalData forecasts that the diagnosed prevalent cases of male infertility are expected to slightly decline from 3,957,575 cases in 2025 to 3,932,895 cases in 2035, at a negative annual growth rate (AGR) of 0.06% across the seven major pharmaceutical markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan).
Male infertility is a medical condition, including disorders such as oligo-,astheno-, terato-, and azoospermia. The condition has low prevalence and can be caused by numerous factors, including genetics, environmental, or as a symptom of another disease.
Scope
Overview of male infertility, including epidemiology, symptoms, diagnosis, and disease management.
Annualized male infertility therapeutics market revenue, cost of therapy per patient, and treatment usage patterns forecast from 2025 to 2035.
Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping, and implications of these factors for the male infertility therapeutics market.
Pipeline analysis: data assessing emerging trends and mechanisms of action under development for male infertility treatment. Any late stage pipeline therapeutics are mapped.
Analysis of the current and future market competition in the global male infertility therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Reasons to Buy
Develop business strategies by understanding the trends shaping and driving the 7MM male infertility therapeutics market.
Drive revenues by understanding the key trends, market segments, and companies likely to impact the 7MM male infertility therapeutics market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and usage of generic therapeutics.
Understand the challenges facing the male infertility therapeutics market from clinical and environmental perspectives
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
ReproNovo SA
CDT Equity Inc
Igyxos SA
Table of Contents
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Oligozoospermia reports